MedTrace Logo

Lipid Emulsions and Liver Function - Results After 5 Years.

NCT04347902 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2020-04-17

No results posted yet for this study

Summary

Intravenous lipid emulsion (ILE) is an essential component of parenteral nutrition (PN), but also one of the key risk factors for development of intestinal failure associated liver disease (IFALD). The aim of the study was to analyse the influence of ILEs on liver function during long term PN.

Conditions

  • Liver Failure
  • Parenteral Nutrition-Related Hepatitis

Interventions

DRUG

Intravenous Lipid Emulsion

Various types of intravenous lipids

Sponsors & Collaborators

  • Stanley Dudrick's Memorial Hospital

    lead OTHER

Principal Investigators

  • Stanislaw Klek, PhD · Stanley Dudrick's Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2020-03-31
Completion
2020-04-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04347902 on ClinicalTrials.gov